199 related articles for article (PubMed ID: 1975176)
1. CD8+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis.
Linker-Israeli M; Quismorio FP; Horwitz DA
Arthritis Rheum; 1990 Aug; 33(8):1216-25. PubMed ID: 1975176
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
[TBL] [Abstract][Full Text] [Related]
3. T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis.
Shivakumar S; Tsokos GC; Datta SK
J Immunol; 1989 Jul; 143(1):103-12. PubMed ID: 2525144
[TBL] [Abstract][Full Text] [Related]
4. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Kanda N; Tsuchida T; Tamaki K
Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
[TBL] [Abstract][Full Text] [Related]
5. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE).
Spronk PE; Horst G; Van Der Gun BT; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1996 Jun; 104(3):446-53. PubMed ID: 9099929
[TBL] [Abstract][Full Text] [Related]
6. In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone.
Murakami M; Kumagai S; Sugita M; Iwai K; Imura H
Clin Exp Immunol; 1992 Nov; 90(2):245-50. PubMed ID: 1424281
[TBL] [Abstract][Full Text] [Related]
7. The effect of adherent cell-derived factors on immunoglobulin and anti-DNA synthesis in systemic lupus erythematosus.
Jandl RC; George JL; Silberstein DS; Eaton RB; Schur PH
Clin Immunol Immunopathol; 1987 Mar; 42(3):344-59. PubMed ID: 3493867
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta.
Ohtsuka K; Gray JD; Quismorio FP; Lee W; Horwitz DA
Lupus; 1999; 8(2):95-102. PubMed ID: 10192502
[TBL] [Abstract][Full Text] [Related]
9. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
10. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
[TBL] [Abstract][Full Text] [Related]
11. Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c.
Sieling PA; Porcelli SA; Duong BT; Spada F; Bloom BR; Diamond B; Hahn BH
J Immunol; 2000 Nov; 165(9):5338-44. PubMed ID: 11046069
[TBL] [Abstract][Full Text] [Related]
12. Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus.
Suzuki N; Sakane T; Engleman EG
J Clin Invest; 1990 Jan; 85(1):238-47. PubMed ID: 1688569
[TBL] [Abstract][Full Text] [Related]
13. B-cell and T-cell function in systemic lupus erythematosus.
Via CS; Handwerger BS
Curr Opin Rheumatol; 1993 Sep; 5(5):570-4. PubMed ID: 7691138
[TBL] [Abstract][Full Text] [Related]
14. Characterization of lymphocytes that suppress IL-2 production in systemic lupus erythematosus.
Linker-Israeli M; Gray JD; Quismorio FP; Horwitz DA
Clin Exp Immunol; 1988 Aug; 73(2):236-41. PubMed ID: 2972425
[TBL] [Abstract][Full Text] [Related]
15. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
16. Functional properties of CD8 positive lymphocyte subsets in systemic lupus erythematosus.
Horwitz DA; Linker-Israeli M; Gray JD; Lemoine C
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():49-52. PubMed ID: 2956420
[TBL] [Abstract][Full Text] [Related]
17. Increased frequency of circulating follicular helper T cells in lupus patients is associated with autoantibody production in a CD40L-dependent manner.
Xu H; Liu J; Cui X; Zuo Y; Zhang Z; Li Y; Tao R; Li Y; Pang J
Cell Immunol; 2015 May; 295(1):46-51. PubMed ID: 25748125
[TBL] [Abstract][Full Text] [Related]
18. Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.
Anand A; Dean GS; Quereshi K; Isenberg DA; Lydyard PM
Lupus; 2002; 11(8):493-500. PubMed ID: 12220103
[TBL] [Abstract][Full Text] [Related]
19. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.
Llorente L; Zou W; Levy Y; Richaud-Patin Y; Wijdenes J; Alcocer-Varela J; Morel-Fourrier B; Brouet JC; Alarcon-Segovia D; Galanaud P; Emilie D
J Exp Med; 1995 Mar; 181(3):839-44. PubMed ID: 7869046
[TBL] [Abstract][Full Text] [Related]
20. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
al-Janadi M; Raziuddin S
J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]